Broad-Spectrum Antivenom Offers Hope Against Deadly African Snakebites
Kongens Lyngby, Denmark – A newly developed antiserum demonstrates effectiveness against multiple African snake species simultaneously, offering a potential breakthrough in treating snakebite envenomation, researchers from the Technical University of denmark and an international team have announced. The findings were published today in the journal Nature (2025; DOI: https://doi.org/10.1038/s41586-025-09661-0).
Snakebite envenomings represent a notable, yet often overlooked, global health crisis. The World Health Association (WHO) recognizes it as one of 21 neglected tropical diseases, contributing to an estimated 100,000 to 150,000 deaths annually. Critically, three times that number – hundreds of thousands of individuals – survive with life-altering, permanent disabilities, including amputations and extensive tissue damage.Current treatment relies on species-specific antivenoms, which are often unavailable or impractical to administer in regions with diverse snake populations. This new broad-spectrum approach aims to address that critical gap.